What is ClearPoint Neuro's cash ratio?

ClearPoint Neuro (CLPT) reported cash ratio of 3.9× in Q1 2026.

How has ClearPoint Neuro's cash ratio changed year-over-year?

ClearPoint Neuro's cash ratio increased by 113.5% year-over-year, from 1.8× to 3.9×.

What is the long-term trend for ClearPoint Neuro's cash ratio?

Over 5 years (2020 to 2025), ClearPoint Neuro's cash ratio has grown at a -7.0% compound annual growth rate (CAGR), from 6.3× to 4.4×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

ClearPoint Neuro CLPT Cash ratio

Cash ratio at other companies

AbbottABT

0.4×-0.1×

Boston ScientificBSX

0.2×+0.1×

IAR

Integra LifeSciencesIART

0.7×+0.4×

Zimmer Biomet HoldingsZBH

0.1×-0.5×

MedtronicMDT

0.2×0.0×

Orthofix Medical Inc.OFIX

0.7×+0.3×

Other financials

Income statement

See full

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

See full

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total equity$18.8M-5.7%

Total assets$93.4M+211%

Cash flow

See full

Operating cash flow-$8.0M-29.1%

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

See full

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

See full

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

See full

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Calculated from ClearPoint Neuro’s reported figures.

cash and equivalents/total current liabilities=3.9×

Based on the most recent quarter.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ClearPoint Neuro's cash ratio?: ClearPoint Neuro (CLPT) reported cash ratio of 3.9× in Q1 2026.
How has ClearPoint Neuro's cash ratio changed year-over-year?: ClearPoint Neuro's cash ratio increased by 113.5% year-over-year, from 1.8× to 3.9×.
What is the long-term trend for ClearPoint Neuro's cash ratio?: Over 5 years (2020 to 2025), ClearPoint Neuro's cash ratio has grown at a -7.0% compound annual growth rate (CAGR), from 6.3× to 4.4×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.